Oct 30, 2018 4:00 pm EDT Cerecor Receives Rare Pediatric Disease Designation for CERC-801 for Patients with Inborn Error of Metabolism
Aug 1, 2018 6:30 am EDT Cerecor Announces First Patient Enrolled in Phase I Trial for Neurogenic Orthostatic Hypotension (nOH) in Parkinson’s Disease
Apr 2, 2018 8:00 am EDT Cerecor Inc. Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2017
